Literature DB >> 21411767

Effect of helium breathing on intercostal and quadriceps muscle blood flow during exercise in COPD patients.

Ioannis Vogiatzis1, Helmut Habazettl, Andrea Aliverti, Dimitris Athanasopoulos, Zafeiris Louvaris, Antonella LoMauro, Harrieth Wagner, Charis Roussos, Peter D Wagner, Spyros Zakynthinos.   

Abstract

Emerging evidence indicates that, besides dyspnea relief, an improvement in locomotor muscle oxygen delivery may also contribute to enhanced exercise tolerance following normoxic heliox (replacement of inspired nitrogen by helium) administration in patients with chronic obstructive pulmonary disease (COPD). Whether blood flow redistribution from intercostal to locomotor muscles contributes to this improvement currently remains unknown. Accordingly, the objective of this study was to investigate whether such redistribution plays a role in improving locomotor muscle oxygen delivery while breathing heliox at near-maximal [75% peak work rate (WR(peak))], maximal (100%WR(peak)), and supramaximal (115%WR(peak)) exercise in COPD. Intercostal and vastus lateralis muscle perfusion was measured in 10 COPD patients (FEV(1) = 50.5 ± 5.5% predicted) by near-infrared spectroscopy using indocyanine green dye. Patients undertook exercise tests at 75 and 100%WR(peak) breathing either air or heliox and at 115%WR(peak) breathing heliox only. Patients did not exhibit exercise-induced hyperinflation. Normoxic heliox reduced respiratory muscle work and relieved dyspnea across all exercise intensities. During near-maximal exercise, quadriceps and intercostal muscle blood flows were greater, while breathing normoxic heliox compared with air (35.8 ± 7.0 vs. 29.0 ± 6.5 and 6.0 ± 1.3 vs. 4.9 ± 1.2 ml·min(-1)·100 g(-1), respectively; P < 0.05; mean ± SE). In addition, compared with air, normoxic heliox administration increased arterial oxygen content, as well as oxygen delivery to quadriceps and intercostal muscles (from 47 ± 9 to 60 ± 12, and from 8 ± 1 to 13 ± 3 mlO(2)·min(-1)·100 g(-1), respectively; P < 0.05). In contrast, normoxic heliox had neither an effect on systemic nor an effect on quadriceps or intercostal muscle blood flow and oxygen delivery during maximal or supramaximal exercise. Since intercostal muscle blood flow did not decrease by normoxic heliox administration, blood flow redistribution from intercostal to locomotor muscles does not represent a likely mechanism of improvement in locomotor muscle oxygen delivery. Our findings might not be applicable to patients who hyperinflate during exercise.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411767     DOI: 10.1152/ajpregu.00671.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  11 in total

Review 1.  Skeletal muscle vasodilatation during maximal exercise in health and disease.

Authors:  Jose A L Calbet; Carsten Lundby
Journal:  J Physiol       Date:  2012-10-01       Impact factor: 5.182

2.  A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstruction.

Authors:  Hubert Truebel; Sandra Wuester; Philip Boehme; Hinnerk Doll; Sven Schmiedl; Jacek Szymanski; Thorsten Langer; Thomas Ostermann; Dirk Cysarz; Petra Thuermann
Journal:  Eur J Appl Physiol       Date:  2019-03-08       Impact factor: 3.078

Review 3.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

4.  Effect of expiratory loaded breathing during moderate exercise on intercostal muscle oxygenation.

Authors:  Quentin Bretonneau; Aurélien Pichon; Claire de Bisschop
Journal:  Multidiscip Respir Med       Date:  2020-10-26

5.  Acute respiratory muscle unloading by normoxic helium-O₂ breathing reduces the O₂ cost of cycling and perceived exertion in obese adolescents.

Authors:  Desy Salvadego; Alessandro Sartorio; Fiorenza Agosti; Gabriella Tringali; Alessandra Patrizi; Antonella Lo Mauro; Andrea Aliverti; Bruno Grassi
Journal:  Eur J Appl Physiol       Date:  2014-09-12       Impact factor: 3.078

6.  Effect of high flow nasal cannula on peripheral muscle oxygenation and hemodynamic during paddling exercise in patients with chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Tien-Pei Fang; Yen-Huey Chen; Hsiu-Feng Hsiao; Hsiu-Ying Cho; Ying-Huang Tsai; Chung-Chi Huang; Meng-Jer Hsieh; Huang-Pin Wu; Hui-Ling Lin
Journal:  Ann Transl Med       Date:  2020-03

7.  Effects of Heliox in Stable COPD Patients at Rest and during Exercise.

Authors:  Matteo Pecchiari
Journal:  Pulm Med       Date:  2012-10-10

8.  Three weeks of respiratory muscle endurance training improve the O2 cost of walking and exercise tolerance in obese adolescents.

Authors:  Hailu K Alemayehu; Desy Salvadego; Miriam Isola; Gabriella Tringali; Roberta De Micheli; Mara Caccavale; Alessandro Sartorio; Bruno Grassi
Journal:  Physiol Rep       Date:  2018-10

9.  Contrasting the physiological effects of heliox and oxygen during exercise in a patient with advanced COPD.

Authors:  Zafeiris Louvaris; Ioannis Vogiatzis
Journal:  Breathe (Sheff)       Date:  2019-09

10.  Acute respiratory muscle unloading improves time-to-exhaustion during moderate- and heavy-intensity cycling in obese adolescent males.

Authors:  Hailu Kinfu Alemayehu; Desy Salvadego; Gabriella Tringali; Roberta De Micheli; Mara Caccavale; Alessandro Sartorio; Bruno Grassi
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.